Evidence map›Paper›PMID 38931947›Full record

ArticlePharmaceutics2024

Multistage Nanocarrier Based on an Oil Core-Graphene Oxide Shell.

Immacolata Tufano, Raffaele Vecchione, Valeria Panzetta, Edmondo Battista, Costantino Casale, Giorgia Imparato, Paolo Antonio Netti

Abstract read
In one paragraph

Article in Pharmaceutics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Immacolata TufanoCenter for Advanced Biomaterials for Health Care (CABHC), Istituto Italiano di Tecnologia, 80125 Naples, Italy.
Raffaele VecchioneCenter for Advanced Biomaterials for Health Care (CABHC), Istituto Italiano di Tecnologia, 80125 Naples, Italy.ORCID 0000-0002-8831-7891
Valeria PanzettaCenter for Advanced Biomaterials for Health Care (CABHC), Istituto Italiano di Tecnologia, 80125 Naples, Italy.ORCID 0000-0001-6174-4116
Edmondo BattistaCenter for Advanced Biomaterials for Health Care (CABHC), Istituto Italiano di Tecnologia, 80125 Naples, Italy.ORCID 0000-0003-0915-9176
Costantino CasaleInterdisciplinary Research Centre on Biomaterials (CRIB), University of Naples Federico II, 80138 Naples, Italy.
Giorgia ImparatoCenter for Advanced Biomaterials for Health Care (CABHC), Istituto Italiano di Tecnologia, 80125 Naples, Italy.ORCID 0000-0002-3500-0380
Paolo Antonio NettiCenter for Advanced Biomaterials for Health Care (CABHC), Istituto Italiano di Tecnologia, 80125 Naples, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Potent synthetic drugs, as well as biomolecules extracted from plants, have been investigated for their selectivity toward cancer cells. The main limitation in cancer treatment is the ability to bring such molecules within each single cancer cell, which requires accumulation in the peritumoral region followed by homogeneous spreading within the entire tissue. In the last decades, nanotechnology has emerged as a powerful tool due to its ability to protect the drug during blood circulation and allow enhanced accumulation around the leaky regions of the tumor vasculature. However, the ideal size for accumulation of around 100 nm is too large for effective penetration into the dense collagen matrix. Therefore, we propose a multistage system based on graphene oxide nanosheet-based quantum dots (GOQDs) with dimensions that are 12 nm, functionalized with hyaluronic acid (GOQDs-HA), and deposited using the layer-by-layer technique onto an oil-in-water nanoemulsion (O/W NE) template that is around 100 nm in size, previously stabilized by a biodegradable polymer, chitosan. The choice of a biodegradable core for the nanocarrier is to degrade once inside the tumor, thus promoting the release of smaller compounds, GOQDs-HA, carrying the adsorbed anticancer compound, which in this work is represented by curcumin as a model bioactive anticancer molecule. Additionally, modification with HA aims to promote active targeting of stromal and cancer cells. Cell uptake experiments and preliminary penetration experiments in three-dimensional microtissues were performed to assess the proposed multistage nanocarrier.

Indexed as

graphene oxide quantum dotsmulti-stage approachoil/water nano-emulsion

Identifiers

PMID38931947
PMCPMC11207637

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.